• Citer

Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study

par Subbiah, Vivek;Braña, Irene;Longhi, Alessandra;Boni, Valentina;Delord, Jean Pierre;Awada, Ahmad ;Boudou-Rouquette, Pascaline;Sarantopoulos, John;Shapiro, Geoffrey G.I.;Elias, Anthony A.D.;Ratan, Ravin;Fernández, Cristian;Kahatt, Carmen;Cullell-Young, Martin;Siguero, Mariano;Zeaiter, Ali;Chawla, Sant
Référence Clinical cancer research, 28, 13, page (2762-2770)
Publication Publié, 2022-07

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study
Auteur:	Subbiah, Vivek; Braña, Irene; Longhi, Alessandra; Boni, Valentina; Delord, Jean Pierre; Awada, Ahmad; Boudou-Rouquette, Pascaline; Sarantopoulos, John; Shapiro, Geoffrey G.I.; Elias, Anthony A.D.; Ratan, Ravin; Fernández, Cristian; Kahatt, Carmen; Cullell-Young, Martin; Siguero, Mariano; Zeaiter, Ali; Chawla, Sant
Informations sur la publication:	Clinical cancer research, 28, 13, page (2762-2770)
Statut de publication:	Publié, 2022-07
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1078-0432
	info:doi/10.1158/1078-0432.CCR-22-0696
	info:scp/85133334171
	info:pmid/35486638